(109 days)
No
The description focuses on the mechanical design and function of a stent system and its delivery catheter, with no mention of AI or ML capabilities.
Yes
The device is intended for the treatment of esophageal obstructions caused by malignant neoplasms, which is a therapeutic purpose.
No
Explanation: The device is a stent system used for treatment of esophageal obstructions and not for diagnosis.
No
The device description clearly describes a physical, self-expanding stent made of Nitinol wire, a delivery catheter, and a handle with levers. These are hardware components, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for the treatment of esophageal obstructions produced by malignant neoplasms. This is a therapeutic intervention, not a diagnostic one.
- Device Description: The description details a physical implant (a stent) and its delivery system. This is consistent with a medical device used for treatment, not for analyzing samples from the body to diagnose a condition.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, tissue, urine, etc.) to provide information for diagnosis, monitoring, or treatment decisions.
IVD devices are used in vitro (outside the body) to analyze samples. This device is used in vivo (inside the body) for treatment.
N/A
Intended Use / Indications for Use
The Medtronic InStent EsophaCoil Esophageal Stent System is intended for use in the treatment of esophageal obstructions produced by malignant neoplasms.
The Medtronic InStent EsophaCoil Proximal and Distal Extensions are intended for extending previously placed esophageal stents exhibiting tumor overgrowth or tumor ingrowth on the upper or lower portion of the existing stent respectively.
Product codes
EWZ
Device Description
The Medtronic InStent EsophaCoil Esophageal Stent is a self-expanding, tightly wound spiral Nitinol wire coil which is flared at both ends to enhance fixation. The EsophaCoil Extension is identical to the EsophaCoil Esophageal Stent except that only one end is flared. The non-flared end of the EsophaCoil Extension is inserted into an implanted esophageal stent to extend the length of the stent. The delivery catheter is identical to the currently marketed device. The variable release handle utilizes three independently sliding levers located on the catheter 's proximal end that can release the stent in any sequence order; distal release, center release, or proximal release depending upon which of the sliding levers is pulled first, second, or third.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
esophageal
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Corrosion testing was performed to evaluate the safety of the device. No other testing was deemed necessary for the new or modified devices.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.3610 Esophageal prosthesis.
(a)
Identification. An esophageal prosthesis is a rigid, flexible, or expandable tubular device made of a plastic, metal, or polymeric material that is intended to be implanted to restore the structure and/or function of the esophagus. The metal esophageal prosthesis may be uncovered or covered with a polymeric material. This device may also include a device delivery system.(b)
Classification. Class II. The special control for this device is FDA's “Guidance for the Content of Premarket Notification Submissions for Esophageal and Tracheal Prostheses.”
0
JAN - 8 1988
510(k) NOTIFICATION SUMMARY
Medtronic InStent EsophaCoil Esophageal Stent System and EsophaCoil Proximal and Distal Extension Systems
General Provisions A.
| Submitter's Name | Medtronic InStent |
|---|---|
| Submitter's Address | 6271 Bury Drive |
| Eden Prairie, Minnesota 55346 | |
| Contact Person | John R. Dalpee |
| Senior Quality Assurance/Regulatory Affairs | |
| Manager | |
| Classification Name: | Esophageal Endoprosthesis 21 CFR Part 878.3610 |
| Common or Usual Name: | Esophageal Endoprosthesis |
| Proprietary Name: | EsophaCoil Esophageal Stent System |
| EsophaCoil Proximal and Distal Extension Systems |
Name of Predicate Device B.
These devices are considered substantially equivalent to the Medtronic InStent EsophaCoil Esophageal Stent System. (K944187 and K955041)
C. Device Description
The Medtronic InStent EsophaCoil Esophageal Stent is a self-expanding, tightly wound spiral Nitinol wire coil which is flared at both ends to enhance fixation. The EsophaCoil Extension is identical to the EsophaCoil Esophageal Stent except that only one end is flared. The non-flared end of the EsophaCoil Extension is inserted into an implanted esophageal stent to extend the length of the stent. The delivery catheter is identical to the currently marketed device. The variable release handle utilizes three independently sliding levers located on the catheter 's proximal end that can release the stent in any sequence order; distal release, center release, or proximal release depending upon which of the sliding levers is pulled first, second, or third.
D. Intended Use
The Medtronic InStent EsophaCoil Esophageal Stent System is intended for use in the treatment of esophageal obstructions produced by malignant neoplasms.
The Medtronic InStent EsophaCoil Proximal and Distal Extensions are intended for extending previously placed esophageal stents exhibiting tumor overgrowth or tumor ingrowth on the upper or lower portion of the existing stent respectively.
1
Summary of Technological Characteristics E.
The modified EsophaCoil Esophageal Stent is identical to the currently marketed device with the exception of the surface preparation. The EsophaCoil Extension Systems are identical to the currently marketed device with the exception that the EsophaCoil Extension has only one flared end, rather than two flared ends as in the EsophaCoil Esophageal Stent.
F. Non-Clinical and Clinical Test Summary
Corrosion testing was performed to evaluate the safety of the device. No other testing was deemed necessary for the new or modified devices.
G. Conclusions
Based on the testing performed and the nature of the changes, it was concluded that the modified devices are substantially equivalent to the currently marketed device. The construction, materials packaging and sterilization methods
H. Other Information
No other information was deemed necessary for the determination of substantial equivalence of the EsophaCoil Esophageal Stent modifications or the new models, the EsophaCoil Distal and Proximal Extension Systems.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three wavy lines representing its wings, positioned to the right. Encircling the eagle is the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" in a circular arrangement.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN - 9 1998
Mr. John R. Dalpee Senior Quality Assurance/Regulatory Affairs Manager Medtronic InStent 6271 Bury Drive Eden Prairie, Minnesota 55346
Re: K973584
Trade Name: Medtronic InStent EsophaCoil Esophageal Stent System and EsophaCoil Extension System Regulatory Class: III Product Code: EWZ Dated: September 19, 1997 Received: September 22, 1997
Dear Mr. Dalpee:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations - Title 21, -----Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements , as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for
3
Page 2 - Mr. John R. Dalpee
devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits vour device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Page of of )
510(k) Number (if known):
Device Name: Medtronic InStent EsophaCoil Esophageal Stent System and EsophaCoil Extension System
Indications For Use:
The Medtronic InStent EsophaCoil Esophageal Stent System is intended for use in the treatment of esophageal obstructions produced by malignant neoplasms.
The Medtronic InStent EsophaCoil Distal Extension System is intended for use in extending previously implanted esophageal stents exhibiting tumor overgrowth on the distal side of the stent. 1
The Medtronic InStent EsophaCoil Proximal Extension System is intended for use in extending previously implanted esophageal stents exhibiting turnor overgrowth on the _ proximal side of the stent.
(PLEASE DO NOT WRITE BELOW THIS LINE- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) | |
|---|---|
| Division of General Restorative Devices | |
| 510(k) Number |
| Prescription Use | |
|---|---|
| (Per 21 CFR 801.109) |
OR
| Over-The-Counter Use | |
|---|---|
| (Optional Format 1-2-96) |